Newcomers are flocking to the market, drawn by a growing base of targets and the promise of increased fund sizes.
Vastly expanded powers by the US health department means PE firms will need to provide greater transparency and accountability in how they run their healthcare businesses.
Banks that are unaware of the extent of their exposure to private equity could face ‘severe, unexpected losses’, according to the UK’s central bank.
As the public markets continue to shrink, the case for GPFG’s entry into private equity is not only one of returns but, increasingly, one of diversification.
A flurry of recent products suggests ELTIF 2.0 is gaining traction with managers and investors alike.
With Kaiser Permanente returning to market with its third billion-plus portfolio in as many years and more first-timers taking the plunge, secondaries players are hopeful more LPs will take a regular approach to the strategy in the years to come.
Though the stars seem to be aligning for India’s private equity market, the absence of consistent DPI remains a stumbling block.
Could alternative interpretations of offshoring private equity fund structures spread to other parts of the world?
The country was consistently singled out at PEI Group’s NEXUS event as one of the most exciting places to invest in this year.
The PE industry remains upbeat as it addresses slow fundraising, artificial intelligence and ESG issues, among others, according to panellists at PEI's NEXUS 2024 summit this week.